105 related articles for article (PubMed ID: 218013)
1. Prodrugs of 9-(beta-D-arabinofuranosyl)adenine 2. Synthesis and evaluation of a number of 2',3'- and 3',5'-di-O-acyl derivatives.
Baker DC; Haskell TH; Putt SR; Sloan BJ
J Med Chem; 1979 Mar; 22(3):273-9. PubMed ID: 218013
[TBL] [Abstract][Full Text] [Related]
2. Prodrugs of 9-beta-D-arabinofuranosyladenine. 1. Synthesis and evaluation of some 5'-(O-acyl) derivatives.
Baker DC; Haskell TH; Putt SR
J Med Chem; 1978 Dec; 21(12):1218-21. PubMed ID: 722731
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of a series of 2'-O-acyl derivatives of 9-beta-D-arabinofuranosyladenine as antiherpes agents.
Baker DC; Kumar SD; Waites WJ; Arnett G; Shannon WM; Higuchi WI; Lambert WJ
J Med Chem; 1984 Mar; 27(3):270-4. PubMed ID: 6321734
[TBL] [Abstract][Full Text] [Related]
4. 2-Substituted derivatives of 9-alpha-D-arabinofuranosyladenine and 9-alpha-D-arabinofuranosyl-8-azaadenine.
Montgomery JA; Shortnacy AT; Arnett G; Shannon WM
J Med Chem; 1977 Mar; 20(3):401-4. PubMed ID: 191611
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of N6- or 8-substituted 9-(beta-D-arabinofuranosyl)-adenines and their antiviral activities against herpes simplex and vaccinia viruses.
Kaneko M; Kimura M; Nishimura T; Shimizu B
Chem Pharm Bull (Tokyo); 1977 Oct; 25(10):2482-9. PubMed ID: 201386
[No Abstract] [Full Text] [Related]
6. Anti-herpes activity of the adenine arabinoside analog, 2'-azido-2'-deoxy-beta-D-arabinofuranosyladenine.
Cermak-Mörth CM; Christian R; Unger FM
Biochem Pharmacol; 1979 Jul; 28(13):2105-8. PubMed ID: 224885
[No Abstract] [Full Text] [Related]
7. Influence of 1-dodecylazacycloheptan-2-one (Azone) on the topical therapy of cutaneous herpes simplex virus type 1 infection in hairless mice with 2',3'-di-O-acetyl-9-beta-D-arabinofuranosyladenine and 5'-O-valeryl-9-beta-D-arabinofuranosyladenine.
Shannon WM; Westbrook L; Higuchi WI; Sugibayashi K; Baker DC; Kumar SD; Fox JL; Flynn GL; Ho NF; Vaidyanathan R
J Pharm Sci; 1985 Nov; 74(11):1157-61. PubMed ID: 4087174
[TBL] [Abstract][Full Text] [Related]
8. 1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil. A highly selective antiherpes simplex agent.
Mansuri MM; Ghazzouli I; Chen MS; Howell HG; Brodfuehrer PR; Benigni DA; Martin JC
J Med Chem; 1987 May; 30(5):867-71. PubMed ID: 3033244
[TBL] [Abstract][Full Text] [Related]
9. 1-beta-D-arabinofuranosyl-1H-imidazo[4,5-c]pyridine (ara-3-deazaadenine).
Montgomery JA; Clayton SJ; Chiang PK
J Med Chem; 1982 Jan; 25(1):96-8. PubMed ID: 6283083
[No Abstract] [Full Text] [Related]
10. Activity of (+)-cyclaradine (Sch 31172) against herpes simplex virus in vitro and in vivo.
Schwartz J; Ostrander M; Butkiewicz NJ; Lieberman M; Lin C; Lim J; Miller GH
Antimicrob Agents Chemother; 1987 Jan; 31(1):21-6. PubMed ID: 3032089
[TBL] [Abstract][Full Text] [Related]
11. Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.
Shannon WM; Arnett G; Schabel FM; North TW; Cohen SS
Antimicrob Agents Chemother; 1980 Oct; 18(4):598-603. PubMed ID: 6255863
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiviral activity of various esters of 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine.
Martin JC; Tippie MA; McGee DP; Verheyden JP
J Pharm Sci; 1987 Feb; 76(2):180-4. PubMed ID: 3033195
[TBL] [Abstract][Full Text] [Related]
13. Nucleoside conjugates V: Synthesis and biological activity of 9-(beta-D-arabinofuranosyl)adenine conjugates of corticosteroids.
Hong CI; Kirisits AJ; Nechaev A; Buchheit DJ; West CR
J Pharm Sci; 1984 Feb; 73(2):278-80. PubMed ID: 6707903
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro antiviral activity of 3'-O-acyl derivatives of 5'-amino-5'-deoxythymidine: potential prodrugs for topical application.
Lin TS
J Pharm Sci; 1984 Nov; 73(11):1568-71. PubMed ID: 6097664
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluations of certain 2-halo-2'-substituted derivatives of 9-beta-D-arabinofuranosyladenine.
Secrist JA; Shortnacy AT; Montgomery JA
J Med Chem; 1988 Feb; 31(2):405-10. PubMed ID: 3339610
[TBL] [Abstract][Full Text] [Related]
16. Carbocyclic arabinosyladenine, an adenosine deaminase resistant antiviral agent.
Vince R; Daluge S
J Med Chem; 1977 Apr; 20(4):612-3. PubMed ID: 191615
[No Abstract] [Full Text] [Related]
17. An evaluation of certain chain-extended analogues of 9-beta-D-arabinofuranosyladenine for antiviral and cardiovascular activity.
Baker DC; Crews RP; Haskell TH; Putt SR; Arnett G; Shannon WM; Reinke CM; Katlama NB; Drach JC
J Med Chem; 1983 Oct; 26(10):1530-4. PubMed ID: 6312045
[TBL] [Abstract][Full Text] [Related]
18. 5'-O-D-valyl ara A, a potential prodrug for improving oral bioavailability of the antiviral agent vidarabine.
Shen W; Kim JS; Mitchell S; Kish P; Kijek P; Hilfinger J
Nucleosides Nucleotides Nucleic Acids; 2009; 28(1):43-55. PubMed ID: 19116869
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of vidarabine prodrugs as antiviral agents.
Shen W; Kim JS; Kish PE; Zhang J; Mitchell S; Gentry BG; Breitenbach JM; Drach JC; Hilfinger J
Bioorg Med Chem Lett; 2009 Feb; 19(3):792-6. PubMed ID: 19097789
[TBL] [Abstract][Full Text] [Related]
20. Biological activities and modes of action of 9-alpha-D-arabinofuranosyladenine and 9-alpha-D-arabinofuranosyl-8-azaadenine.
Bennett LL; Allan PW; Shaddix SC; Shannon WM; Arnett G; Westbrook L; Drach JC; Reinke CM
Biochem Pharmacol; 1981 Aug; 30(16):2325-32. PubMed ID: 6271140
[No Abstract] [Full Text] [Related]
[Next] [New Search]
